Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00920062 · ClinicalTrials.gov registry record
Measurement of Recirculation During Venovenous Extracorporeal Membrane Oxygenation (VV ECMO)
A clinical trial, sponsored by Transonic Systems.
- Completed
- Registry status
- 16
- Enrollment target
NCT00920062 is a clinical trial that has completed, run by Transonic Systems. The registered enrollment target is 16 participants.
The verdict
NCT00920062 has completed, sponsored by Transonic Systems.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
This study is to test the usefulness of ultrasound dilution recirculation measurements in patients receiving venovenous extracorporeal membrane oxygenation as therapy. The ultrasound dilution measurements determine the efficiency of support provided by venovenous extracorporeal membrane oxygenation. At the present time there are no other devices available to make recirculation measurements.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-06 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00920062
The ClinicalTrials.gov registry entry for NCT00920062 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Transonic Systems, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00920062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00920062 about?
NCT00920062 is a clinical study titled "Measurement of Recirculation During Venovenous Extracorporeal Membrane Oxygenation (VV ECMO)". This study is to test the usefulness of ultrasound dilution recirculation measurements in patients receiving venovenous extracorporeal membrane oxygenation as therapy. The ultrasound dilution measurements determine the efficiency of support provided by venovenous extracorporeal membrane oxygenation....
What is the current status of trial NCT00920062?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2007-06. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT00920062?
This trial is sponsored by Transonic Systems, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.